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ABSTRACT 
Lipins are a family of proteins that have critical functions in the control of fat 
storage and energy homeostasis. Biochemically, lipins have two functions. They provide 
an enzymatic activity (phosphatidate phosphatase or PAP activity) in the glycerol-3 
phosphate pathway that leads to the production of storage fats (triacylglycerols). In 
addition, they play a role in the regulation of genes in the cell nucleus as transcriptional 
co-regulators. The PAP activity of lipins has been widely studied in a number of 
organisms. However, the transcriptional co-regulator function is not as well described in 
the literature. The transcriptional function of lipins depends on its nuclear translocation 
caused by the presence of a nuclear localization signal (NLS) in the protein. Data from 
our lab have shown that expression of Lipin protein lacking the NLS (LipinΔNLS) from 
a transgene leads to a disruption of timely development of Drosophila melanogaster. 
This suggests that Lipin has nuclear roles in the control of development.  
The overarching goal of this project was to further examine nuclear roles of Lipin 
in Drosophila melanogaster. LipinΔNLS mutant was generated by CRISPR/Cas9 
mutagenesis. Phenotypic and genetic analyses of the LipinΔNLS mutant indicate that 
nuclear functions of Lipin are essential for animal survival. LipinΔNLS and LipinΔPAP 
mutants complement each other restoring enzymatic and nuclear functions in these 
transheterozygous animals. Generation of a LipinΔNLS mutant provides a variety of 
future directions that can be pursued by our laboratory. 
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I. INTRODUCTION 
A. Background 
Diseases such as obesity, insulin resistance, diabetes, dyslipidemia, hypertension, 
coronary heart disease, and cancer strongly suggest the importance of proper regulation 
of adipogenesis and fat storage in adipocytes in humans (Garg, 2004; Smyth, 2006). 
Excessive or reduced levels of triglyceride (TAG) synthesis directly influence modes of 
lipid accumulation in liver and skeletal muscle.  
A random accident in 1981 has led to the discovery of lipin gene family. Jackson 
Laboratory observed an unusual mouse phenotype (Bar Harbor, Maine). The animals 
appeared normal after birth, but with time, developed fatty liver and 
hypertriglyceridemia (Langer et al., 1989). On average, mutant animals maintained 25% 
lower body weight than normal animals. Mutant animals were given a name fatty liver 
dystrophy (fld) and were characterized as lacking in adipose tissue and insulin 
resistance (Rue et al., 2000).  
Lipin-1 gene was first described in 2001 through cloning experiments in fatty 
liver dystrophy background (Péterfy et al., 2001).  
B. Lipin Gene Family 
The family of lipin proteins exists in a variety of species ranging from yeast to 
humans. Among the different species, lipin proteins have evolutionary conserved 
regions called NLIP and CLIP domains implying their importance in the function of the 
proteins. The CLIP domain in mammals, as well as Drosophila melanogaster contains 
the haloacid dehydrogenase motif DXDXT which corresponds to phosphatases (PAP) 
and the transcription binding motif LXXIL (Han et al., 2006; and Finck* et al., 2006). 
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Two of mammalian lipin proteins have been shown to act as transcriptional co-
activators in a manner independent from their PAP activity by interaction with 
proliferator-activated receptor (PPAR) α, PPAR co-activator-1α (PGC-1α), and PPARγ 
(Koh et al., 2008; Finck* et al., 2006; and Donkor et al., 2009). 
C. Molecular Functions of Lipin 
Lipin has two primary functions within a cell. First, lipin can act as phosphotidate 
phosphatase (PAP) in a diacylglycerol (DAG) synthesis pathway. This pathway includes 
a series of steps involving addition of acyl groups to glycerol phosphate. The conversion 
of phosphotidate to DAG is catalyzed by lipin-1 in mammals. DAG can further be 
converted into triacylglycerol (TAG) or neutral phospholipids, phosphotidylcholine, and 
phosphotidylethanolamine (Vance et al., 2004).  
The second function is lipin’s ability to regulate gene expression through a 
mechanism involving nuclear entry. Initially, chromatin immunoprecipitation (ChiP) of 
lipin’s homolog in yeast (SMP2) showed proteins association with the promoter region 
of genes, which code for phospholipid biosynthesis (Santos-Rosa et al., 2005). It was 
later shown by Finck et al. that mammalian lipin-1 acts as a transcriptional coactivator 
of fatty acid oxidation genes under caloric restriction conditions (Finck et al., 2006). 
First, lipin-1 gene expression was shown to be activated by fasting among other factors 
in PGC-1α dependent manner (Finck et al., 2006). A gene expression profiling 
(microarray) was conducted in wild-type mice to evaluate genes highly expressed under 
starvation conditions, as a result, lipin-1 transcription was observed to be highly 
induced. However, mice homozygous for PGC-1α knockout were not able to respond to 
starvation with activation of lipin-1 gene. Second, overexpression of lipin-1 in mouse 
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liver using an adenoviral vector (Ad-lipin) showed an effect on increase of transcription 
of many genes associated with fatty acid uptake and utilization along with nuclear 
receptor PPARα; the Kreb’s cycle enzymes; and proteins involved in mitochondrial 
oxidative phosphorylation (Finck et al., 2006). On the other hand, the expression of 
genes involved in fatty acid and TAG synthesis showed a decline as a response to lipin-1 
overexpression. Third, Glutathione S-transferase (GST) pulldown assay showed physical 
interaction of PPARα with the LXXIL motif of lipin-1 indicating that nuclear functions 
of lipin-1 are independent from its PAP activity (Finck et al., 2006). 
Phosphorylation is a mechanism used to regulate cellular localization of lipin-1 
(Harris et al., 2007). Mammalian lipin-1 has been shown to become phosphorylated in 
response to insulin and amino acids and dephosphorylated in response to oleic acids 
and epinephrine (Huffman et al., 2002; Harris et al., 2007; and Kim et al. 2007). 
Expression of Lpin1 is induced by presence of glucocorticoids, steroid hormones (Zhang 
et al., 2008). 
The functional mechanisms of PAP have been studied for over 30 years, unlike 
the transcription activation mechanisms that remain mostly uncertain until today. 
D. Lipins in Mammals 
Lipin-1 gene was first described in 2001 (Péterfy et al., 2001). Since then, three lipin 
genes were identified in mammals, lipin-1, lipin-2,   and lipin-3, which have been 
extensively studied in mice. It has been shown that lipin-1 deficiency in mice results in 
development of lipodystrophy and its overexpression results in obesity (Phan et al., 
2005). Lipin-2 and lipin-3 were discovered after lipin-1 based on 60% amino acid 
identity (Péterfy et al., 2001). Each of the three lipin genes has a unique expression 
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pattern. Lipin-1 accounts for most of PAP activity in adipose tissue, bones, and muscles, 
but not in the liver (Donkor et al., 2007; Harris et al., 2007).  
Correct expression of lipin-1 is essential for adipose differentiation and TAG storage 
(Péterfy et al., 2001; Phan et al., 2004). Transgenic studies in mice show that incorrect 
lipin-1 function in skeletal muscles leads to reduced fatty acid oxidation and thus obesity 
(Phan et al., 2005). Lipin-2 is mostly expressed in liver, kidneys, brain, and lungs; and 
lipin-3 has lower expression levels but is detectable in liver and visceral tissues (Donkor 
et al., 2007). 
Various mutations in N-LIP domain of lipin-1 have been documented to be 
associated with metabolic disorders in humans (Péterfy et al., 2001). Lipin-1 deficiency 
was shown to cause muscle pain, weakness, and myogloburia in children (Zeharia et al., 
2008). Unlike in mice, lipin-1 mutation does not cause lipodystrophy in humans, which 
may be explained by compensatory effects of lipin-2 (Donkor et al., 2007).  
Silent mutations in C-LIP domain of lipin-1 have been shown to be associated with 
statin drugs treatment (Zeharia et al., 2008). These drugs are commonly used to treat 
hypercholesterolemia and some patients develop muscle pain and myopathy in response 
to the treatment (Sirvert et al., 2008). 
Missense and nonsense mutations in C-LIP domain of lipin-2 have been shown to 
associate with recurring osteomyelitis, cutaneous inflammation, anemia, and psoriasis 
(El-Shanti et al., 2007; Ferguson et al., 2005; Majeed et al., 2001; and Milhavet et al., 
2008). 
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Many studies have identified the importance of PAP and transcriptional coactivator 
function of lipin-1 in mice and humans. Specifically, a study by Nadra et al. shows that 
lipin-1 PAP deficiency in mice leads to fatty liver dystrophy (fld) mutant mouse strains 
(2008). This phenotype is described by accumulation of phosphotidate in adipose tissue 
and periphery leading to activation of mitogen-activated protein kinase/extracellular 
regulated kinase (MEK-Erk) in Schwann cells. The impact of the same mutation is not 
as severe in humans, but patients with lipin-1 deficiency also show significant 
accumulation of phosphotidate and its intermediates (Zeharia et al., 2008). An 
important feature of fld in mice worth mentioning is that these mutant animals develop 
fatty liver and hypertriglyceridemia during neonatal period (Langer et al., 1989). This 
finding indicates that PAP activity of lipin-1 is non-essential for hepatic TAG synthesis. 
Further studies suggest that PAP activity if not required for suppression of TAG 
synthesis; however, LXXIL, or transcriptional coactivator activity and PPARα binding 
are required (Chen et al., 2008).  
E. Use of Drosophila melanogaster in Studying Transcriptional 
Coactivator Functions of Lipin  
Unlike humans, Drosophila melanogaster possess only one lipin gene. Lack of the 
redundancy and high functional similarity between lipin-1 protein in mammals and 
Drosophila Lipin protein make the fruit fly a highly valuable asset in studying lipid 
metabolism.  
Drosophila mechanism for lipid storage and processing is very similar to that in 
mammals. Lipids are stored in form of TAGs and cholesterol esters; both of these forms 
are primarily stored in the fat body of the animal, which is similar to the function of 
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mammalian adipocytes (Kuhnlein, 2011; Murphy, 2012). Along with oenocytes, 
dispersed clusters of cells located in the cuticle, fat body performs metabolic regulation 
of fat storage similar to mammalian liver (Gutierrez et al., 2007). In mammals, β-cells of 
the pancreas regulate carbohydrate and lipid metabolism (Saltiel and Khan, 2001). In 
Drosophila, the corpora cardiaca, a portion of the larval ring gland, secrete glucagon-
like adipokinetic hormone (AKH) to fulfill the same function as pancreas in mammals 
(Kim and Rulifson, 2002). The genome of Drosophila contains seven genes that code for 
insulin-like peptides and the central brain contains insulin-producing cells, which have 
the same function as β-cells of the pancreas (Rulifson et al., 2002). 
The   goal of this study was to gain a better understanding of nuclear roles of lipin 
using Drosophila melanogaster as a model. It has been shown by Ugrankar et al. that 
Drosophila lipin is required for normal fat tissue development and normal animal 
development (2011). The nuclear localization signal (NLS) located in the NLIP region of 
the protein allows for lipin’s translocation into the nucleus where it can then interact 
directly with transcription control proteins. The current project was divided into two 
major parts.  
In the first part, CRISPR/Cas9 mutagenesis was utilized to generate a lipin allele 
lacking the NLS coding sequence. The expectation was to create a targeted double 
stranded break in the lipin gene and allow the DNA to be repaired used homology 
directed repair (HDR) mechanism using a template lacking the NLS coding sequence to 
generate a LipinΔNLS. The generated mutant was to be analyzed for significant 
phenotypic changes compared to controls. 
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The second part of the project focused on Lipin’s nuclear functions in different 
tissues of Drosophila. Malpighian tubules and the ring gland were selected as the organs 
of interest based on previous observations of Lipin expression in the nucleus or the 
cytoplasm of these tissue (Ugrankar et al., 2011). It has been shown in the past that 
LipinΔNLS transgene has a dominant negative effect on the endogenous Lipin and 
prevents its translocation into the nucleus (Schmitt et al., 2015). The GAL4/UAS system 
was used to express LipinΔNLS or LipinWT (control) in the ring gland; in addition, 
Lipin[RNAi] expression was used in Malpighian tubules. In both cases, the data were 
collected as percent pupariation and the experimental groups were compared to the 
control groups using unpaired t-test.  
The goal of the current study is to identify the nuclear function of Lipin and its effect 
on animal development. The hypothesis is that lipin’s inability to translocate into the 
nucleus will cause developmental complication for the animals as well as prevent proper 
cell response to nutritional changes through defective gene regulation which would 
normally be controlled by Lipin as a transcriptional coactivator. 
II. MATERIALS AND METHODS 
A. Fly Food Preparation 
Fly food was prepared in batches to make 6 L. The cauldron was first pre-heated 
at setting 8-9 (to allow water to boil). One hundred and eight grams of yeast were 
measured and combined with 600 mL of warm tap water and thoroughly mixed. Three 
hundred and sixty six grams of corn meal were added to yeast mixture and mixed 
thoroughly. In a separate container, 492 g of malt extract and 64 g of agar were 
combined. Once the cauldron reached the set temperature, 6 L of tap water were added. 
8 
 
Yeast and cornmeal mixture was immediately added to the water. Once the yeast and 
cornmeal have been mixed with water, agar and malt were slowly added while stirring. 
The food was brought to slow boiling and 78 mL of corn syrup were added. The food was 
allowed to cool to room temperature. Forty five mL of propionic acid and 60 mL of 
Tegosept were added and mixed. Once all ingredients were mixed, the food was 
distributed into vials with a sterile 60 mL syringe.  
B. Cloning of gRNA into pCFD3 Plasmid 
 Cloning of pCFD3 plasmid, Figure 1, (Addgene, Cambridge, MA, Cat.# 49410) 
was completed in order to introduce guide RNA (gRNA) to be used as a guide for Cas9 
nuclease to the site for double stranded cut at NLS sequence of the lipin gene. 
Figure 1. pCFD3 allows for expression of gRNA under control of the Drosophila U6:3 
promoter. The plasmid has a pVallium22 backbone manufactured by Norbert Perrimon 
and Jian-Quan Ni at Harvard. pCFD3-dU6:3gRNA was a gift from Simon Bullock. Total 
vector size is 6,248 bp. The vector is ampicillin resistant. Ref: Optimized CRISPR/Cas 
tools for efficient germline and somatic genome engineering in Drosophila (Port et al., 
2014).  
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The plasmid linearization was completed using Shrimp Alkaline Phosphatase 
(rSAP) protocol (New England Biolabs, Ipswich, MA, M0371). Plasmid, 6 μL, 1 μL 
Restriction Endonuclease (BbsI cut site), 5 μL 40x Restriction Enzyme Buffer, and 36 
μL of sterile water were combined and incubated at 37°C shaker overnight. The 
following day 2 μL of rSAP were added to restriction digest (RED) and incubated for 1 
hour at 37°C; at the expiration of the hour, rSAP was inactivated at 65°C for 20 minutes. 
The linearized plasmid was analyzed on a 0.7% agarose gel, which was ran for 30 
minutes at 120 V to check for complete digestion. If the restriction digest was successful, 
all RED was ran on a 1% agarose gel for 30 minutes at 120 V.  Following gel 
electrophoresis, the linearized plasmid was gel purified using QIAquick Gel Extraction 
Kit (Qiagen, Germantown, MD, 28704). The DNA was excised from the gel and weighed. 
The QG buffer was added to the DNA at the ratio of 3:1, μL to mg. The DNA and QG 
were incubated at 50°C for 10 minutes. The sample was vortexed and if a color change 
from yellow to orange was observed 10 μL of 3 M sodium acetate were added. 
Isopropanol was then added to the mixture at ratio 1:1, μL, to the original weight of the 
gel in mg and the ingredients were thoroughly mixed. The mixture was then transferred 
to a column and span down at 13,000 rpm for 1 minute. The column was washed with 
500 μL of QG. Once the QG was discarded, the column was allowed to incubate at room 
temperature for 1 minute. The DNA was washed with 750 μL of PE Buffer and the 
flowthrough was discarded. To elute DNA, the column was transferred to a sterile tube 
and 30 μL of EB were added. The column with EB was incubated for 4 minutes after 
which the DNA was collected by centrifugation. The quality and quantity of the purified 
plasmid DNA were evaluated by running a 0.7% agarose gel for 30 minutes at 120 V. 
RED product was used as a control for size and quantity of circularized plasmid. 
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The oligonucleotides used for gRNA construction were different between the first 
CRISPR/Cas9 run and the next two, but in all cases the following general procedure was 
followed. The oligonucleotides were originally diluted in 1xTAE to concentration 100 
μM. PCR reaction was set up to anneal the ssOligonucleotides: 1 μL of each 
ssOliogonucleotide, 1 μL T4 Ligation Buffer, 6.5 μL sterile water, and o.5 μL T4 PNK 
(New England Biolabs). The thermocycler was set for hot start and the oligonucleotide 
annealing was completed at 37°C for 30 minutes, 95°C for 5 minutes, and cooled to 25°C 
at the rate of 5°C per minute. The quantity of oligonucleotide annealing was evaluated 
by gel electrophoresis. A 2% agarose gel was used to visualize annealed oligonucleotides. 
The gel was ran for 20 minutes at 120 V. 
 A ligation reaction for the oligonucleotides and the linearized plasmid was set up. 
Digested plasmid, 50 ng or 3.035 μL, was combined with 1 μL of annealed 
oligonucleotides at concentration of 1:200, 1.5 μL 10x T4 Ligation Buffer, 1 μL of 1xT4 
DNA Ligase, and 9.5 μL of sterile water (New England Biolabs). Ligation took place at 
room temperature for 30 minutes. Circularized plasmid with gRNA was transformed 
into competent E. coli.  
A laboratory stock of E. coli (DH5α) in glycerol kept at -80°C was thawed on ice 
for 20 minutes. Once the cells are thawed, 1:1 volume of 0.1 M sodium chloride was 
added. The purified ligation product, 10 μL, was added to the cells and the ingredients 
were incubated on ice for 30 minutes. Following the incubation, the cells with ligation 
product were heat shocked at 42°C for 45 seconds and immediately transferred to ice for 
2 minutes. To these cells, 800 μL of optimal broth (SOB) with catabolite repression and 
added glucose (SOC) were added. The cells were then incubated at 37°C for 60 minutes 
while shaking at 225 rpm. Some of the incubated cells were then plated on Luria broth 
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(LB) agar plate with ampicillin (0.01 g ampicillin into 100 mL of liquid media), which 
was incubated at 37°C overnight. Leftover cells were centrifuged at 3,381 rcf for 2 
minutes; the supernatant was then discarded until 200 μL were left, at which point cells 
were resuspended and plated on a second LB agar with ampicillin plate.  
Five colonies of cells from the LB agar plate were transferred using aseptic 
techniques into 3 mL of LB plus ampicillin and incubated on shaker at 37°C overnight; 
these cells were used for the second and third round of CRISPR. Plasmid sequences 
were confirmed by sequencing with Eurofins (Louisville, KY) using primers: 
5′ sequencing primer ACCTACTCAGCCAAGAGGC 
3′ sequencing primer TGCATACGCATTAAGCGAAC 
Once the plasmid sequencing results confirmed lack of secondary mutations and 
presence of gRNA, cells were preserved in glycerol as a stock at -80°C. 
 Clone 5 was obtained from -80°C and thawed. The culture was spread with a loop 
on LB-Amp plate and incubated at 37°C overnight. The following day, a colony from the 
LB-Amp plate was transferred into 3 mL of liquid LB-Amp (0.01 g ampicillin into 100 
mL LB) and incubated at 37°C overnight while shaking. QIAprep Spin Mini Kit was used 
to harvest plasmid from the E.coli (Qiagen). The overnight culture of Clone 5 was 
centrifuged at 8,000 rpm for 3 minutes at room temperature. The cells were then re-
suspended in 400 µL Buffer P1 and transferred to microcentrifuge tubes. Four hundred 
µL of Buffer P2 were added to the tubes and the contents were mixed by inverting for no 
longer than 5 minutes. Next, 400 µL of Buffer N3 were added to the tubes mixed by 
inverting. The contents were centrifuged at 13,000 rpm for 10 minutes. The supernatant 
was extracted and applied to columns by pipetting.  The columns were centrifuged at 
13,000 rpm for 1 minute and the flowthrough was discarded. The columns were then 
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washed with 750 µL of PE and centrifuged for 1 minute at 13,000 rpm. Following 
centrifugation, the flowthrough was discarded. The columns were then transferred to 
collection tubes and centrifuged at 13,000 rpm for 1 minute to ensure complete riddance 
of PE. After the expiration of 1 minute, the columns were again transferred to sterile 
collection tubes. The DNA was eluted with 30 µL of EB. Once EB was added, the 
samples were incubated for 1 minute at room temperature and then centrifuged for one 
minute at 13,000 rpm. After centrifugation, the EB was transferred back into the 
columns, which were centrifuged as before one more time. 
Plasmid concentration in the purified sample was determined by gel 
electrophoresis. A 0.7% agarose gel was made by adding agarose and 1 x TAE (Tris, 
glacial acetic acid, and o.5 M EDTA). The mixture was first microwaved for 1 minute and 
mixed. After the initial minute, the solution was microwaved in intervals of 30 seconds 
until all agarose was dissolved. The solution was allowed to cool to room temperature at 
which point SYBR-Safe (Invitrogen, Thermo Fisher Scientific, Carlsbad, CA, #1821848) 
was added and the solution was slowly swirled. Once mixed, agarose was poured into a 
mold and allowed to polymerize for at least 30 minutes. Gel was loaded with 6 µL of 1 kb 
ladder (New England Biolabs; lot# 1391612) in Sample Buffer at ratio 1:5 (New England 
Biolabs, lot#0141607) and 1 µL of plasmid in 5 µL of Sample Buffer. The electrophoresis 
was completed at 120 V for 30 minutes. The plasmid used for CRISPR injections had 
concentration 2-5 µg/µL. 
C. CRISPR/Cas9 Mutagenesis: Run I 
The use of CRISPR/Cas9 mutagenesis was intended to create a fly line that 
carries a lipin allele that lacks nuclear localization signal (NLS) in order to observe a loss 
of function (LOS) phenotype.  
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The preparatory steps for embryo injections included the following procedures. A 
gRNA CGACTTCTTGCGCCGCTTCT (TGG) (TGG is the PAM) was cloned into pCFD3 
from Addgene using protocol from Eurofins as described above (Addgene, Cambridge, 
MA; Eurofins, Louisville, KY). A pair of oligonucleotides generated for cloning of the 
sgRNA into pCFD3 had the following sequences (Eurofins): 
ProtoNLS 1: 5’-GTCGCGACTTCTTGCGCCGCTTCT-3’  
ProtoNLS 2: 5’-AAACAGAAGCGGCGCAAGAAGTCG-3’  
This cloning procedure generated gRNA, which was used as a guide for Cas-9 nuclease.  
Single-stranded donor oligonucleotide (ssOligo) was synthesized complimentary 
to a portion of lipin at NLS but lacking NLS (Eurofins). This oligonucleotide was a donor 
used for homologous DNA repair with the following sequence: 
5’-
GACGTTAACCTCACCACGGTCACAACCAGCGAAGCCACCAAGGAGGTGTCCAA
GAGCAAAACCTCGCAAATGAAGAAGAATGCCCAGCGCAAGAACTCTTCAAGCA
GCTCATTGGGCAGCGCCGG-3’ 
Plasmid and the gRNA were combined by adding 50 µL ultrapure water, pCFD3-
ΔNLS at 500 ng/µL, and ΔNLS ssOligo at 100 ng/µL. These components were then sent 
for embryonic injections into y[1] M{vas-Cas9}ZH-2A w[1118]/FM7c embryos 
(Bloomington Stock #51323; BestGene, Chino Hills, CA). Approximately 300 injected 
embryos were injected and sent to the laboratory. 
Stable stocks were established for this CRISPR run using the general 
methodology described below in Section F (Establishing Stable Stocks); however, the 
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guide RNA that used here did not work properly so the section describes in detail only 
how CRISPR III stocks were established. 
D. CRISPR/Cas9 Mutagenesis: Run II 
Due to CRISPR I not being successful, a new gRNA was cloned into pCFD3 
plasmid (Addgene). The new gRNA sequence was CCAAGAGCAAAACCAAGAAG (CGG) 
(CGG was the PAM). 
The oligonucleotides (Eurofins) for cloning the gRNA were modified here: 
ProtoNLS2-1: 5’-GTCGCCAAGAGCAAAACCAAGAAG -3’ 
ProtoNLS2-2: 5’-AAACCTTCTTGGTTTTGCTCTTGG-3’ 
The ssOligo used was the same as for CRISPR I (Eurofins). This oligonucleotide 
was a donor used for homologous DNA repair with the following sequence: 
5’-
GACGTTAACCTCACCACGGTCACAACCAGCGAAGCCACCAAGGAGGTGTCCAA
GAGCAAAACCTCGCAAATGAAGAAGAATGCCCAGCGCAAGAACTCTTCAAGCA
GCTCATTGGGCAGCGCCGG-3’ 
Plasmid and gRNA were co-injected into vas-Cas9 embryos (Bloomington 
#51323; BestGene, Chino Hills, CA) in a mixture combining 50 µL ultrapure water, 
pCFD3-ΔNLS at 500 ng/µL, and ΔNLS ssOligo at 100 ng/µL. Approximately 300 
injected embryos were injected and sent to the laboratory. 
The stable stocks were established for this CRISPR run using the general 
methodology described below in Section F (Establishing Stable Stocks); however, the 
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ssOligo donor that was used here did not work properly so the section describes in detail 
only how CRISPR III stocks were established. 
E. CRISPR/Cas9 Mutagenesis: Run III  
The procedure for the third CRISPR run was identical to the previous times 
except a new 127-bp oligonucleotide designed according to rules defined by Richardson 
et al. (2016).  The new information about CRISPR mutagenesis was different from what 
was known before. It was established that single-stranded oligonucleotide donor needs 
to be complementary to non-target strand (in other words that strain that contains 
PAM). The donor has to be asymmetric and overlap Cas9 cut site with 36 base pair PAM 
on distal side (upstream of PAM) and 91 base pair extension on PAM proximal side 
(downstream of PAM). In the first attempt at CRISPR the donor was generated correctly 
but the guide RNA did not work. In the second attempt at CRISPR, the donor was 
generated incorrectly but the guide RNA worked. 
The single stranded oligonucleotide was generated at Integrated DNA 
Technologies (Coralville, IA). The sequence of the new oligonucleotide was as follows:   
5’- 
GCGTCTCCGCCGAAGGCAAATCACCGCCGCCGGCGCTGCCCAATGAGCTGCTT
GAAGAGTTCTTGCGCTGGGCATTCTTCTTCATTTGCGAGGTTTTGCTCTTGGAC
ACCTCCTTGGTGGCTTCGCT -3’  
 The generated oligonucleotide was 39014.1 g/mole molecular weight and 4 nmole 
contained 156.06 µg. 
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F. Establishing Stable Stocks 
After the embryos were received from BestGene, the larvae were allowed to 
pupariate. The pupae were separated into individual vials to generate the founder (F) 
stock. A series of crosses was performed in order to establish balanced stocks for 
preservation of potential mutants.  
The first cross was of the founder fly and a stock that carries a balancer marked 
with CyO on the second chromosome vas-Cas9/vas-Cas9 (Y); Mut/+ x w[*]; 
P{w[+mc]=GAL4-Hsp70.PB}2/CyO, on1;2. Seventy six founder flies were crossed 
individually with four virgin females if they were males or with 3 males if they were 
female. Cy flies from the progeny (P) were selected for the next cross.  
The second set of crosses was performed to introduce a balancer marked with 
CyO-GFP. The potential expected crosses were Vas-Cas9/+ or Vas-Cas9/Y or +/Y; Mut 
or +/CyO x  w; P[w+; UASakt]1.1/CyO-GFP. Out of 76 original stocks 60 stocks were 
successful with the progeny to be used for the second set of crosses. For each of the 60 
founder crosses, 3 flies were selected to be mated individually with flies carrying CyO-
GFP to generate total of 120 crosses (F1). The procedure for these crosses was identical 
to the first set of crosses. GFP pupae were selected from each stock. 
The adults that eclosed from selected pupae from the second cross (F1) were 
allowed to mate. The expected mating schemes were +/+(Y); Mut or +/CyO-GFP x 
+/+(Y); Mut or +/CyO-GFP (this was our stock). Non-GFP pupae (F2) were selected 
from the progeny to establish homozygous stocks that potentially carry the mutation. If 
the cross produced only heterozygous progeny they were kept as a stock to be analyzed 
as well.   
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G. DNA Extraction from Single Flies 
Single flies from stocks of interest were transferred into individual tubes and kept 
on ice for 5 minutes. Squishing buffer was prepared on ice by mixing 965 µL of distilled 
water, 10 µL of 1M Tris-Cl, pH 7.4, 10 µL 100 mM EDTA, 5 µL NaCl, and 10 µL 20 
mg/mL proteinase K (New England Biolabs, #P8107S). Each fly was squished with a 
pipette tip and mixed with 50 µL of Squishing Buffer. The samples were then incubated 
at room temperature for 20 minutes. Next, the samples were transferred to 95°C for 5 
minutes. After heating, the samples were iced for 5 minutes and centrifuged for five 
minutes at 14,000 rpm. The DNA was stored at 4°C up to a week. 
H. PCR Test for Mutations: CRISPR/Cas9 Run I  
Two different approaches were used to screen for LipinΔNLS mutants at this run. 
The first approach was to use two primer sets allowing us to evaluate presence of the 
mutation based on the product presence or size. The second approach was to use 
sequencing to evaluate the nucleotide composition of the flies in testing. 
The goal of using the first set of primers was to have primers in which one of 
them would hybridize to the 18 nucleotides of NLS, meaning that if the NLS was excised 
using Cas9 then there would be no product visible on the gel and if the NLS was intact 
then the product size would be 201 base pairs. If the animals were to be heterozygous for 
ΔNLS then the final product would appear less than in wild-type animals. 
Primer pair 2 (NLS2F and NLS2R): 5’ GGCGGACTCGGACTCGCTGGAC    
3’ TGCGACTTCTTGCGCCGCTTCTT   
 The second set of primers was used in order to visualize product size difference is 
the 18 base pair deletion took place. The primers were design to yield a very short 
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product. If the NLS was present then the product size would be 108 base pairs, and if the 
NLS was absent then the product size would be 90 base pairs.  
Primer pair 4 (NLS4F and NLS4R): 5’ AGCCACCAAGGAGGTGTCCAAGA    
3’ GCGCTGCCCAATGAGCTGCTTGAA   
The PCR reactions for the two sets of primers were set up similarly to each other 
with the exception of the primer type. The general master mix contained 12.5 μL of One 
Taq 2x Master Mix with GC Buffer (New England Biolabs, #04835), 2.5 μL One Taq 
High GC Enhancer (New England Biolabs, #B9026A), 2.5 μL 10 μM forward primer, 2.5 
μL 10 μM reverse primer, 2.5 μL of sterile water and 2.5 μL of genomic DNA. The 
thermocycler setting included initial denaturation at 95°C for 3 minutes, following 
denaturation at the same temperature for 30 seconds, annealing at 64°C for PP2 or 62°C 
for PP4 for 30 seconds, extension at 72°C for 30 seconds, final extension at 72°C for 10 
minutes and hold at 4°C. The number of cycles used was 30. Due to the small product 
size for primer pair 2 the gel electrophoresis was done on a 2% agarose gel; for primer 
pair 4, the gel electrophoresis had to be performed on a 3% agarose gel and using 50 bp 
ladder (New England Biolabs). 
Sample sequencing was completed by Eurofins and two primer sets were used. 
The need for designing a separate primer set for sequencing purposes rose form the fact 
that the above product size were too small given the location of the NLS and the quality 
of sequencing reads. The first primer pair was (PP1): 
5’ CGCTGGACAACCAAAGCAAA 
3’ CTTGGACAGGGGACTAGGGA 
The second primer pair was (PP2): 
 5’ CAAGGAGGAGCCCAAGGAAG 
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 3’ CTCCGTGTCGTCGAAGAAGT 
The PCR reaction procedure for these two primer sets for sequencing was set up in the 
same way as described above. The thermocycler setting for the PP1 included initial 
denaturation at 95°C for 3 minutes, following denaturation at the same temperature for 
30 seconds, annealing at 57°C for 30 seconds, extension at 72°C for 1 minute, final 
extension at 72°C for 10 minutes and hold at 4°C. The number of cycles used was 32. 
The thermocycler setting for PP2 were identical to those of PP1 for the exception of 
annealing temperature which was 59°C. The DNA was then processed as described in 
PCR purification, Gel electrophoresis, and Sending samples for sequencing sections. 
I. PCR Test for Mutations: CRISPR/Cas9 Run II  
Oligo485’s forward (5’-CGCTGGACAACCAAAGCAAA-3’) and reverse (5’-
CTCCGTGTCGCTGAAGAAGT-3’) were used to amplify the template. The PCR reaction 
was set up for total volume of 50 µL by mixing 25 µL of 2x One Taq 2x Master Mix with 
GC Buffer, 5 µL of DNA template, 1 µL of forward primer 10 µM concentration, 1 µL 
reverse primer 10 µM concentration, and 18 µL of sterile nuclease-free water. The 
thermocycler setting were set up with initial denaturation for three minutes at 94°C, 
94°C for 30 seconds as the first step of 30 cycles, annealing at 54°C for 30 seconds as 
the second step, extension at 68°C for one minute as the third step, final extension took 
place at 68°C for 10 minutes, and 4°C were held forever. 
About half way through screening Oligo485 was likely contaminated and 
Oligo625’s forward (5’-CAAACAGGCACACCGACAAC-3’) and reverse (5’-
TCCGTGTCGCTGAAGAAGTG-3’) were used to amplify the template for second half of 
the samples. The PCR reaction was set up for total volume of 50 µL by mixing 25 µL of 
One Taq 2x Master Mix with GC Buffer, 5 µL of DNA template, 5 µL of forward primer 5 
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µM concentration, 5 µL reverse primer 5 µM concentration, and 10 µL of sterile 
nuclease-free water. The thermocycler setting were set up with initial denaturation for 
three minutes at 95°C, 95°C for 30 seconds as the first step of 30 cycles, annealing at 
57°C for 30 seconds as the second step, extension at 72°C for one minute as the third 
step, final extension took place at 72°C for 4 minutes, and 4°C were held forever. 
The DNA was processed as described in PCR purification, Gel electrophoresis, 
and Sending samples for sequencing sections. 
J. PCR Test for Mutations: CRISPR/Cas9 Run III  
Oligo485’s, same as used in CRISPR Run II analysis, were used to amplify the 
template. The PCR reaction was set up for total volume of 50 µL by mixing 25 µL of 2x 
One Taq Polymerase in Standard Buffer, 5 µL of DNA template, 1 µL of forward primer 
10 µM concentration, 1 µL reverse primer 10 µM concentration, and 18 µL of sterile 
nuclease-free water. The thermocycler setting were set up with initial denaturation for 
three minutes at 94°C, 94°C for 30 seconds as the first step of 30 cycles, annealing at 
54°C for 30 seconds as the second step, extension at 68°C for one minute as the third 
step, final extension took place at 68°C for 10 minutes, and 4°C were held forever. 
The DNA was processed as described in PCR purification, Gel electrophoresis, 
and Sending samples for sequencing sections. 
K. PCR Purification 
PCR products were column purified because the DNA was subsequently 
sequenced and Taq, other nucleotides, and primers used in the PCR reaction would 
interfere with sequencing reads if not removed. PCR product purification was 
accomplished using QIAquick PCR Purification Kit (Qiagen, 28106). A 5:1 volume of PB 
was added to empty tubes, which was used to precipitate DNA. PCR reaction was added 
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into PB. The contents of the tube were mixed thoroughly by inversion. If the mixture 
turned purple then 10 µL of 3 M sodium acetate were added and mixed by inversion. 
The sample was then transferred to columns and centrifuged at 13,000 rpm for one 
minute. The flowthrough was discarded following centrifugation. Seven hundred and 
fifty µL of PE were added to the columns for DNA washing and the columns were 
centrifuged at 13,000 rpm for one minute. The flowthrough was discarded after 
centrifugation and the columns were centrifuged in the same manner as before the 
second time. The columns were transferred to sterile collection tubes after the second 
centrifugation. Lastly, 30 µL of EB were used to elute DNA. EB was added to the center 
of the column and was incubated for one minute at room temperature. The samples 
were centrifuged for one minute at 13,000 rpm. Following centrifugation, the 
flowthrough was transferred back into the column and all samples were centrifuged at 
the same settings again. 
L. Testing Purified PCR Sample Concentrations by Gel 
Electrophoresis 
Before sending samples for sequencing, all purified PCR products were ran on 
either 0.7% or 1% agarose gel to test for purity and quantity to ensure successful 
sequencing results. The gels were freshly prepared by mixing 1xTAE with 
electrophoresis grade agarose (MP Biomedicals, Solon, Ohio, Cat #820723). The 
mixture was heated in a conventional microwave for one minute and stirred. The 
process was repeated at 10 second intervals until agarose was completely dissolved. The 
agarose in solution was then cooled to approximately 37°C and 10 µL of SYBR-Safe DNA 
Gel Stain was added and mixed at that point (Thermo Fisher Scientific). The solution 
was then swirled and poured into prepared mold. The comb was inserted and the gel 
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was allowed to polymerize for at least 30 minutes. A 1 kb ladder (New England Biolabs, 
lot# 1391612) in Sample Buffer (New England Biolabs, lot# 0141607) in ration 1:5 was 
used as a DNA size marker. Typically, 1 µL of each sample in 5 µL of Sample Buffer were 
run to test sample concentration. The gel was run at 100 V for 45 minutes. 
M. Sending Samples for Sequencing 
All Sanger Sequencing was done by Eurofins. On average, 10 µL of QIAquick 
purified PCR reactions at 42 ng/µL concentration were transferred into safe-lock tubes 
and shipped via one-day mail at room temperature. 
N. Determining if Mutant Stocks Produced Homozygous Animals at 
Any Life Stages 
Once sequencing results were analyzed for presence of any mutations and non-
ΔNLS mutants were identified a collection of all different mutants was generated. The 
mutants were analyzed for homozygosity and/or heterozygosity. The stocks were kept at 
25°C for 24 hours and evaluated based on GFP expression at different life cycle stages. If 
the animals expressed GFP then they were considered heterozygous for mutation and if 
animals were non-GFP they were considered homozygous for mutation. 
O. Analyzing Viability of Lipin Mutants and Determining Lethal Phase 
The stocks were also analyzed to determine their viability and lethal phase of 
mutation carrying homozygotes. To achieve this, heterozygous males (M/CyO-GFP) 
from the stocks that carry the mutation were crossed to virgins from 
Df(2R)Exel7095/CyO-GFP (Schmitt et al., 2015). The flies were allowed to lay eggs for 
24 hours at 25°C. The pupae of this cross were evaluated based on GFP expression and 
the data was interpreted as percent of GFP over non-GFP pupa. When lethality was 
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observed, the crosses were further examined to determine the stage at which lethality 
took place (1st, 2nd, 3rd instar larva, or pupa). 
P. Western Blot Analysis of CRISPR/Cas9 Mutants 
Some of non-ΔNLS mutant animals carried frame shift (FS) mutations leading to 
an early stop codon and truncating Lipin protein. Western blot was performed to 
visualize Lipin protein sizes that are present in FS mutants. 
 Whole protein was collected by dissecting all fat bodies from eight 3rd instar 
larvae in 1xPBST per 20µL of Sample Buffer (4 mL glycerol, 2 mL β-mercaptoethanol, 1 
g SDS, 2.5 mL 1 M Tris-Cl pH 6.8, 0.5 mL sterile water, 0.8 mL 0.1% Bromophenol 
blue). Each sample was vigorously vortexed after every larva and all samples were 
heated at 95°C for 5 minutes. If the samples were not used immediately they were stored 
at -20°C. The samples were heated at 95°C for 5 minutes immediately before use. 
Gel preparation was completed following protein extraction. Two glass plates for 
0.75 mm gel were aligned together, small pieces of filter paper were placed between 
clamps of the plate holder and the plates and the clamps were closed. The glass plates 
were checked for alignment at the bottom. Petroleum jelly was used to seal the space at 
the bottom between two plates. The assembly was transferred to a plate rack and fixed 
with a clamp. Next, 15% (or 10%) resolving gel was prepared according the recipe by 
adding ingredients in the following order: 8x Lower Buffer, pH 8.8 (Tris 36.34 g, SDS 
0.8 g, pH adjusted with HCl and water added up to 100 mL), 30% 0.8% bis-acrylamide 
(Acrylamide 60 g, bis-Acrylamide 1.6 g, 200 mL of water), 75% sucrose, pure distilled 
water, 5% ammonium persulfate, and TEMED. Resolving gel was transferred between 
two glass plates with a pipette until the solution reached the green bar of the plate 
holder. Isopropanol was pipetted over the resolving gel. The gel was allowed to dry at 
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room temperature for 30 minutes. After the expiration of 30 minutes, isopropanol was 
soaked out completely with filter paper. Stacking gel was prepared by mixing 
ingredients in the following order: 4x Upper Buffer, pH 6.8 (Tris 6.06 g, SDS 0.4 g, pH 
adjusted to 6.8 with HCl and water added to 100 mL), 30% 0.8% bis-acrylamide, pure 
distilled water, 5% ammonium persulfate, and TEMED was poured over the stacking gel 
and a 10 well 0.75 mm comb was inserted. The gel was allowed to dry for 30 minutes 
and used right away or stored covered by damp towel and wrapped with plastic wrap at 
4°C for up to a week. 
Electrophoresis of the gel was completed in 500 mL 1x Electrode Buffer (or 
Running Buffer). The gel, or two gels if applicable, were placed into a plastic frame with 
electrodes in such a way that the smaller glass plates face each other and locked into 
place then transferred to a plastic chamber. It was important to ensure that the inner 
chamber created by two plates was sealed well. The 1x Electrode buffer was poured into 
the inner chamber to the top of the plates and the rest of 500 mL was poured into the 
outer chamber. Six µL of Page Ruler Plus Prestained Protein Ladder were loaded as the 
size marker (Thermo Scientific, #26619, Waltham, MA). Ten µL (or as specified) of each 
sample were loaded following the ruler. The electrophoresis was conducted at P1 (200 V, 
240 mA, 100 W) for 60 minutes. 
Following electrophoresis, the gel was blotted onto a cellulose membrane 
(Immobilon P, Sigma-Aldrich, 0.45 μm pore size). To prepare for blotting, two filter 
papers (Whatman, Sigma-Aldrich, 10427706x123429) per gel were cut to be the size of 
the gel (this step was optional if the filter paper fit the gel exactly). The cellulose 
membranes were pre-soaked in methanol for 5 minutes. The filter paper and the 
sponges were soaked in Transfer Buffer. The sandwich for transfer was assembled in the 
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following manner: cathode>transparent side of plastic cassette>one sponge>filter 
paper>membrane>gel>filter paper>one sponge>black side of plastic cassette>anode. 
The sandwich was fixed into position within plastic holder and then placed into a 
transfer chamber. Transfer Buffer was added to cover the entire sandwich. An ice block 
and a stirring bar were added to the chamber. Transfer was completed at P2 (100 V, 200 
mA, 100 V) and ran for 90 minutes on a stirring plate. 
All membranes were blocked in 5% BSA in 1xTBST for 2 hours at room 
temperature while shaking. Primary antibody staining was done using in house made 
anti-Lipin purified antibody generated to recognize NLIP domain of the Lipin protein 
(Ugrankar et al., 2011) diluted in 5% BSA in 1xTBST in concentration 1:1,000. The 
membranes were exposed to primary antibodies overnight, or 10 hours, at 4°C while 
shaking. 
Prior to applying secondary antibody, the primary antibody was discarded and 
the membranes were washed 3 times for 5 minutes each in 1xTBST at room temperature 
while shaking.  After washing, secondary antibody Alkaline Phosphatase-Conjugated 
Affinity Purified Goat Anti-Rabbit IgG (H+L) was applied (Jackson ImmunoResearch, 
#111989, West Grove, PA). Secondary antibody was diluted in 5% BSA in 1xTBST to 
concentration 1:1,000. Membranes were exposed to secondary antibody for 2 hours at 
room temperature while shaking. 
At the expiration of 2 hours, secondary antibody was discarded and the 
membranes were washed with 1xTBST 3 times for 5 minutes at room temperature while 
shaking. Protein detection was completed with SigmaFast BCIP/NBT tablet (Sigma, St. 
Louis, MO, lot#SLBN0689V) diluted in pure water. The membranes were exposed for 
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10 minutes or until the bands were visible. Membrane development was stopped by 
using 10% acetic acid. 
The membranes were allowed to dry and their images were taken. Membrane 
images were captured in BioRad Molecular Image Gel Doc, and software V5.0 (Irvine, 
CA). After opening the program, New Protocol option was selected. The following steps 
were conducted: Application>Blot>Colometric>Imaging Area; Gel Type>Bio-Rad Ready 
Gel; Color>Gray; Position Gel; No Filter; Run Protocol. All images were exported and 
saved in JPEG format. 
Q. Whole Gene Sequencing of LipinΔNLS Mutant 
Once the NLS deletion was identified using Oligo485 it was important to ensure 
that no other secondary mutations occurred in the animals’ genetic background, 
specifically in lipin gene. Whole gene sequencing was used to test for secondary 
mutations. SnapGene (GSL Biotech LLC Chicago, IL) was used to identify 11 primer 
pairs to cover the lipin gene including Lipin-RA cDNA (GH19076) start and 5’ UTR 
through end sites with 3’ UTR. Primer-BLAST (NCBI, Bethesda, MD) was used to design 
22 primers. The following are sequences for 22 primers that were designed (Eurofins) 
(5’ -> 3’): 
Oligo771_PP1_NLS_F AGCGGGAGAGAGAGATTGGA 
Oligo771_PP1_NLS_R AGAAAGGGGGCGAACAAACA 
Oligo727_PP2_NLS_F GATGGAGTCGGAGAGGGAGA 
Oligo727_PP2_NLS_R CTCCTGAGCACTCCCAGTTT 
Oligo710_PP3_NLS_F CCGCAGCAGACCAAAGATGA 
Oligo710_PP3_NLS_R ATGGTGTCGTTGGCCTTGTC 
Oligo710_PP4_NLS_F AGATGAAGCTGGGCGATTCT 
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Oligo710_PP4_NLS_R TTGTGACCGTGGTGAGGTTA 
Oligo720_PP5_NLS_F GGACTCGCTGGACAACCAAA 
Oligo720_PP5_NLS_R GATTGGTGCTCGCTTTGCTG 
Oligo705_PP6_NLS_F GACGACCTTCGACTCCCATC 
Oligo705_PP6_NLS_R CGCAGTGAAGTGCTTGGAAC 
Oligo745_PP7_NLS_F CCATGTGCGGAATGTCGGAG 
Oligo745_PP7_NLS_R AGGTAGGCCGCGAAGTTTG 
Oligo802_PP8_NLS_F CGCCCAACCACTTGAACAAC 
Oligo802_PP8_NLS_R CTGCTCCGGCTTCTTCTCAA 
Oligo738_PP9_NLS_F CGAGCAAAACGGCTACAAGC 
Oligo738_PP9_NLS_R GATTGATTGAGTGGGGTGCG 
Oligo778_PP10_NLS_F GGTTCCGGTGTTGCTCATTA 
Oligo778_PP10_NLS_R ACTTAACTGGCCGACGAACT 
Oligo705_PP11_NLS_F GCGTCTCCACCAAAAACGAA 
Oligo705_PP11_NLS_R GCGCCAGTAGTTGAAGTTGG 
The PCR reactions for each of the 11 primer pairs were set up on ice by combining 
25 µL of 2x One Taq in Standard Buffer (New England Biolabs, #M0482S), 5 µL of 
template DNA, 1 µL of 10 µM forward primer, 1 µL of 10 µM reverse primer, and 18 µL 
of sterile nuclease-free water. 
NEB Tm calculator was used to determine Ta for each of the primers (Ipswich, 
MA). PP2, PP3, PP4, PP6, PP8, PP9, and PP10 were run at Ta of 56°C. PP1, PP5, and 
PP7 were run at Ta of 57°C. And PP11 was run at Ta of 55°C. The PCR cycle was set for 
initial denaturation at 94°C for three minutes, denaturation at 94°C as the first of 30 
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cycle steps, alternating Ta as the second step for 30 seconds, extension for one minute at 
68°C as the third step, final extension for 10 minutes at 68°C, and hold at 4°C forever. 
The PCR products were purified using QIAquick kit and the concentrations were 
established by running 1% electrophoresis gel at 100 V for 45 minutes. The samples 
were sent to Eurofins for sequencing. 
Sequences were aligned to lipin genomic DNA in SnapGene and chromatogram 
peaks were confirmed using FinchTV V1.4 (Geospiza, American Fork, Utah). 
R. Expression of LipinΔNLS or RNAi of Lipin in Malpighian Tubules 
UAS/GAL-4 system and/or RNAi were used to express LipinΔNLS transgene or 
downregulate Lipin in Malpighian tubules to study Lipin’s nuclear localization function 
in the tissue on development of the animals. 
There were two control crosses in the crossing scheme. The first control 
integrated a UAS-LipinΔNLS with w1118, which should not have an effect because a wild-
type animal does not carry a UAS responder.  
UAS-LipinΔNLS  x  w1118 WBG  
 The second control cross combined a UAS responder, or driver, specific for 
tubule principal cells of Malpighian tubules (Bloomington #30835). 
w[*]; P{w[+mW.hs]=GawB}c42  x     w1118 WBG 
 There were four experimental crosses. The first two crosses were intended to use 
two different drivers C42 and Uro-GAL4 (Bloomington #44416) for UAS-LipinΔNLS 
responder in order to overexpress LipinΔNLS in tubule principal cells of Malpighian 
tubules. 
UAS-LipinΔNLS x w[*]; P{w[+mW.hs]=GawB}c42 
UAS-LipinΔNLS x w[*]; P{Uro-GAL4.T}2 
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The second set of experimental crosses utilized UAS/GAL4 system and RNAi to 
block Lipin RNA decreasing protein production in the tubule principal cells of 
Malpighian tubules. The same drivers were used in these crosses as described above. 
UAS-Lipin[RNAi]VDRC36007; on 2nd x w[*]; P{w[+mW.hs]=GawB}c42 
UAS-Lipin[RNAi]VDRC36007; on 2nd x w[*]; P{Uro-GAL4.T}2 
 For all of the crosses, 10 virgins and 5 males were crosses per vial and the same 
batch of food was used for every vial. All animals were allowed to adopt and mate for 24 
hours prior to beginning of the experiment. The first vial where animals were put 
together was not included in data analysis. All six crosses listed above were conducted in 
a biological triplicate, meaning that three independent vials with 10 virgins and 5 males 
were set up at the same time for each of six crosses. A drop of yeast paste was added to 
each vial to encourage mating. For the experiment, the flies were allowed to lay eggs for 
6-8 hours during the day for three days at 29°C. The overnight vials were discarded. 
Once the pupae started forming, their count was taken for all vials every day at the same 
time of the day until no larvae were visible in the food.  
All crosses were conducted in a biological triplicate and all crosses were replicated 
tree times. Upon formation of the first pupae, the number of pupae was counted for all 
crosses every day until no pupae were coming up. The developmental data were 
analyzed as percent pupariation for each of the triplicates. The data were analyzed using 
unpaired t-test to compare the total pupariation percent per day for each of the crosses. 
The percent pupariation data was analyzed and the averages for pulled data from the 
biological replicates and normal replicates were plotted. 
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S. Immunostaining of Lipin in Malpighian Tubules and Fat Bodies 
Malpighian tubules and fat bodies from five w1118 animals were dissected. Fat 
bodies were used as a positive control for Lipin antibody staining and were treated in 
the following steps together with Malpighian tubules. Both organs were fixed in 3.7% 
Formaldehyde in 1 x PBS (10 ml 37% formaldehyde and 90 mL 1 x PBS, pH 7.4) for 30 
minutes at room temperature while shaking. The samples were then washed 4 times for 
10 minutes with 1 x PBST while shaking at room temperature. The samples were blocked 
in 1 x PBST and Normal Donkey Serum (NDS) (Sigma-Aldrich) for 2 hours at room 
temperature while shaking. The primary anti-Lipin antibody (Ugrankar et al., 2011) was 
applied in concentration 1:200 diluted in 1 x PBST in NDS overnight at 4°C while 
shaking.  
The following day, the primary antibody was discarded and the samples were 
washed 4 times for 10 minutes in 1 x PBST at room temperature while shaking. 
Secondary Cy3 Donkey anti-Rabbit antibody (Jackson ImmunoResearch Laboratories) 
diluted in 1 x PBST in NDS at 1:1,000 ratio was applied for 2 hours at room temperature 
while shaking. After the expiration of 2 hours, the samples were washed 4 times for 10 
minutes in 1 x PBST. The samples were then transferred into a drop of SlowFading 
(Fisher Scientific) on a slide. A coverslip was applied over the sample and sealed with 
clear nail polish.  
The images were captured using fluorescent microscope Axio Imager (Zeiss). 
Axiovision program was used to control microscope settings. The tissue was first located 
manually at total magnification of 25x. Once the desired focus was achieved, the 
magnification was adjusted to 100x and at this magnification the images were taken. 
Under the Multidimensional acquisition, Dye was selected as Cy3, Color – Orange, 
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Name – Cy3; During acquisition Workgroup was selected TRITC and After acquisition 
the FL closed was selected. Same settings were used for DAPI. In order to take pictures, 
the optimal exposure was measured first and all views were captured using the same 
exposure per one type of fluorescence. The exposure time for DAPI was 24 ms and for 
TRITC 1000 ms. Scale bars were added to the original images in the same program. 
T. Expression of LipinΔNLS in the Ring Gland 
UAS/GAL4 system was utilized to express LipinΔNLS or LipinWT in different 
parts of the ring gland. Mai60 (Bloomington #30811) is a driver specific for prothoracic 
gland portion, where ecdysone is produced, and Aug21 (Bloomington #30137, CyO 
replaced by CyO-GFP in lab) is a driver specific for corpora allata portion, where 
juvenile hormone is produced.  
The crossing scheme for this experiment included three controls. The first two 
crosses integrated either LipinΔNLS or LipinWT UAS responder into w1118 background 
with no driver. 
UAS-LipinΔNLS x w1118 WBG 
UAS-LipinWT x w1118 WBG 
The last control cross integrated a prothoracic driver Mai60, which may show a 
significant effect on animal development in experimental crosses due to the importance 
of proper ecdysone production to animal development, into a w1118 background with no 
UAS responder. Aug21 was not expected to have a significant effect on the animal 
development and was thus not included in the control crosses. 
P{GawB}Mai60 x  w1118 WBG 
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There were, in addition, three experimental crosses. The first two experimental 
crosses combined a UAS-LipinΔNLS responder with either Mai60 or Aug21 drivers. 
Aug21 driver was prior crossed into a CyO-GFP background for internal control. 
UAS-LipinΔNLS  x P{GawB}Mai60 
UAS-LipinΔNLS x w[*]; P{w[+mW.hs]=GawB}Aug21/CyO-GFP 
The last experimental cross combined a UAS-LipinWT responder with Mai60 
driver. 
UAS-LipinWT x P{GawB}Mai60 
For all of the crosses, 10 virgins and 5 males were crosses per vial and the same batch of 
food was used for every vial. All animals were allowed to adopt and mate for 24 hours 
prior to beginning of the experiment. The first vial where animals were put together was 
not included in data analysis. All six crosses listed above were conducted in a biological 
triplicate, meaning that three independent vials with 10 virgins and 5 males were set up 
at the same time for each of six crosses. A drop of yeast paste was added to each vial to 
encourage mating. For the experiment, the flies were allowed to lay eggs for 6-8 hours 
during the day for three days at 29°C. The overnight vials were discarded. Once the 
pupae started forming, their count was taken for all vials every day at the same time of 
the day until no larvae were visible in the food.  
All crosses were set up in biological triplicates and each one was repeated three 
times. Upon formation of the first pupae, the number of pupae was counted for all 
crosses every day until no pupae were coming up. The developmental data were 
analyzed as percent pupariation for each of the triplicates. The data were analyzed using 
unpaired t-test to compare the total pupariation percent per day for each of the crosses. 
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The percent pupariation data was analyzed and the averages for pulled data from the 
biological replicates and normal replicates were plotted. 
III. RESULTS 
A. Using CRISPR/Cas9 to Generate a LipinΔNLS Mutant 
Lipin is known to have two major functions in a cell: an enzymatic function, 
which allows conversion of phosphatidate phosphatase (PAP) to diacylglycerol (DAG) 
and transcriptional coactivator function (Vance et al., 2004). The goal of this project 
was to study the nuclear function of Lipin and the effects that would be caused by 
Lipin’s inability to enter the nucleus. The primary question was: What will be the 
developmental effect on animals in which Lipin lacks the ability to enter cell nucleus? In 
other words, is nuclear localization of Lipin essential for proper animal development? 
The Lipin protein domain responsible for transcriptional co-activator activity is located 
in close proximity to PAP and the decision was made not to target this domain and 
instead focus on the protein sequence that allows nuclear translocation of Lipin. Nuclear 
localization signal (NLS) was chosen as a target for CRISPR/Cas9 to achieve sequence-
specific lipin modification. The approach was to create a double stranded break in the 
lipin sequence within the NLS and use homology directed repair (HDR) mechanism for 
the DNA repair using a single stranded oligonucleotide that lacks NLS. As a result, the 
expectation was to generate a mutant that lacks 18 base pairs encoding the NLS. This 
deletion of NLS would be an in-frame mutation generating an otherwise normal Lipin 
protein, which is unable to enter the nucleus. CRISPR/Cas9 procedure was attempted 
three times in total. The majority of mutations that were generated, as a result, were 
caused by non-homologous end-joining (NHEJ). However, we were successful in 
identifying a LipinΔNLS mutant, which will be discussed in detail in the next section. 
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We also identified two in-frame mutations that caused a single amino acid deletion at 
position 276 and a triple amino acid deletion at position 273. The mutations that caused 
frame shift resulted in presence of a premature stop codon. As a result, all frame shift 
mutants were predicted to generate a truncated protein of about 300 amino acids on 
average; a normal Lipin protein has the length of 1089 amino acids. There were nine 
frame shift mutants total. Eight of those mutants resulted from nucleotide deletion at 
the site of Cas9 cut and one resulted from nucleotide insertion at the cut site. Figure 1 
lists all mutant lipin alleles that were identified and specifies the sequence modifications 
as well as the effect on protein primary structure. The location of nucleotide 
modifications is described here in the relation to the location of the NLS. NLS starts at 
position 1304 of Lipin-RA cDNA. 
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Figure 2. All CRISPR/Cas9 mutants generated and analyzed by sequencing. The top 
three lines of the table show in-frame mutants that were generated. One of these 
mutants was LipinΔNLS. The other nine mutants were caused by deletions or insertions 
of nucleotides that caused frame shifts. All mutants were analyzed for presence of a 
premature stop codon. The relative location of the mutations is presented in this table in 
relation to the start of the NLS sequence. The first nucleotide within NLS is annotated as 
0; any nucleotide positions that comes before it has a negative number and any 
nucleotide position after it a positive number. 
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B. LipinΔNLS Identification 
The fly lines were tested for the deletion of NLS by sequencing. All fly lines that 
were tested were heterozygotes. The sequences were analyzed by manually aligning the 
nucleotides with double peaks to the wild-type sequence. 
Figure 3. Partial sequence of genomic DNA from lipin locus of heterozygous 
LipinΔNLS larva. The lipin allele lacks the entire NLS coding region 
(AAGAAGCGGCGCAAGAAG encoding KKRRKK). The sequence located directly below 
the chromatogram is a portion of sequence of the wild-type lipin allele that matches a 
set of peaks in the chromatogram. The lipin locus lacking the NLS is located below the 
wild-type sequence and | indicates the point where the two sequences mismatch. 
The sequence alignment indicates a wild-type sequence at the top and the modified 
sequence of the mutant lipin allele at the bottom. The bottom sequence lacks 18 
nucleotides and thus generates double peaks as seen in the chromatogram in Figure 3. 
The Lipin protein generated from the mutagenized sequence will lack the 
KKRRKK amino acids which NLS codes for. To conclude anything else about the mutant 
lipin allele, whole gene sequencing was done. The results of whole gene sequencing are 
discussed later. 
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Determination of LipinΔNLS allele presence was the initial step of the project. Once 
the mutant was identified, it was important to analyze the entire LipinΔNLS gene and 
protein for presence of secondary mutations before any further experiments may be 
conducted. 
C. Testing LipinΔNLS Mutant for Presence of Secondary Mutations 
The LipinΔNLS mutant allele generated by CRISPR/Cas9 mutagenesis was 
analyzed for secondary mutations by sequencing. This measure was taken to ensure that 
any phenotype observed is only due to the loss of NLS. Eleven primer pairs were 
generated that span the region of the lipin gene encoding Lipin-RA transcript covering 
sequence starting at the second downstream promoter. The data generated by 
sequencing was compared to the genomic DNA of the wild-type by aligning the 
sequences in SnapGene (GSL Biotech LLC). Lipin genomic DNA was retrieved from 
FlyBase and nucleotide numbering used in Figure 4 was determined by assigning 
transcription start site “+1.” The regions covered by sequencing were the following: 
transcription start site, 5’UTR, all 11 exons, stop codon, 3’ UTR, and all but first two 
introns. The sequences were analyzed for any mutations in SnapGene. Twenty six 
mutations were found. Eight single nucleotide exchanges take place in upstream 
sequence in relation to the promoter. There is also one single nucleotide exchange in 5’ 
UTR. Six of these mutations were single nucleotide exchanges in the intron regions of 
the LipinΔNLS allele. One single nucleotide exchange on mutant allele caused an amino 
acid change from phenylalanine to tyrosine in position 39. Two single nucleotide 
exchanges present on the mutant allele only caused no amino acid change in the protein 
sequence. Another two single nucleotide exchanges were a result of naturally occurring 
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polymorphism and they were the same for both lipin alleles. The first polymorphism 
resulted in amino acid change from threonine to serine and the second caused a change 
from asparagine to aspartate. The mutant allele also contains three single nucleotide 
exchanges in the 3’ UTR; and both alleles contain a two nucleotide insertion (AA) in 3’ 
UTR. Lastly, the mutant allele contains a single nucleotide exchange in the downstream 
sequence. 
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Figure 4. LipinΔNLS allele sequencing results. Heterozygous animals carrying 
LipinΔNLS were sequenced and both alleles were compared to each other and to the 
genomic sequence available on Flybase to test for secondary mutations and/or naturally 
occurring polymorphisms. UP-upstream; DN-downstream. 
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D. Genetic Complementation between LipinΔNLS and LipinΔPAP 
LipinΔNLS as well as LipinΔPAP are recessive lethal alleles. These alleles are 
maintained over a balancer chromosome that carries a CyO-GFP marker. Expression of 
GFP by the balancer chromosome allows for easy identification of animals homozygous 
or heterozygous for the mutation. The balancer chromosome carries a recessive lethal 
allele, which means GFP marks only heterozygous individuals. We performed a cross 
between LipinΔNLS and LipinΔPAP flies to determine whether the two alleles can 
complement one another and LipinΔNLS/LipinΔPAP animals are viable. Another cross 
performed was between LipinΔPAP and w1118. The potential expected genotypes from 
the crosses are following. 
For cross 1 LipinΔNLS/CyO-GFP x LipinΔPAP/CyO-GFP: 
LipinΔNLS / LipinΔPAP 
LipinΔNLS /CyO-GFP 
LipinΔPAP/CyO-GFP 
About 30% percent of all offspring are expected to be transheterozygous for the mutant 
lipin alleles if they are viable. These offspring will be non-GFP. The other about 70% of 
the offspring are expected to be GFP and heterozygous for one of the mutant lipin 
alleles. 
 For cross 2 LipinΔPAP /CyO-GFP x w1118 we expect 50% of the offspring to be 
heterozygous for the LipinΔPAP allele (non-GFP) and 50% to carry two wild-type lipin 
alleles (GFP). 
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 Figure 5 shows the distribution of the offspring of crosses described above. The 
ratio of non-GFP to GFP pupa indicates that animals who carry LipinΔNLS / LipinΔPAP 
are viable. No obvious developmental delays and pupae size differences were observed. 
The animals were observed into adulthood and both, non-GFP labeled and GFP labeled 
animals produced adults. 
Figure 5. Animals that are transheterozygous for LipinΔNLS and LipinΔPAP are 
viable. GFP is used as a marker for wild-type balancer chromosome and the animals that 
do not display GFP carry only mutant alleles of lipin, LipinΔNLS and LipinΔPAP. (A) 
The ratio of non-GFP to GFP pupae that were counted for each cross were as expected, if 
animals transheterozyous for LipinΔNLS and LipinΔPAP are fully viable. (B) Pupae 
formed by LipinΔNLS/LipinΔPAP larvae are of normal size (non-GFP left half, GFP 
right half; tick marks on the ruler are 1 mm.) 
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E. Characterization of Non-ΔNLS Mutant Lipin Alleles Created by 
CRISPR/Cas9 Mutagenesis 
Most of non-ΔNLS mutant lipin alleles exhibited homozygous lethality. All 
mutants were analyzed for homozygous lethal phase (Figure 6).  
Figure 6. Lethal phase analysis of lipin mutants generated in this study. The “+” sign 
indicates presence of live homozygous animals for the lipin allele at the developmental 
stage listed. The “-” sign indicates presence of only heterozygous animals at the 
developmental stage specified. 
It was observed that only one in-frame mutant lacking a lysine of the NLS made it to 
adulthood as a homozygote (IF_276ΔK). The other in-frame mutant (beside 
LipinΔNLS) had a lysine-threonine- lysine deletion causing early lethality at 1st instar 
larval stage (IF_273ΔKTK). Two of eight frame shift mutants were observed as 1st instar 
larvae but not past this stage. The rest of the frame shift mutants and LipinΔNLS 
animals did not generate any homozygotes at any stage past embryo. 
F. Analysis of CRISPR/Cas9 Mutagenized Animals for Secondary 
Mutations 
The data we obtained for the lethality stage of CRISPR/Cas9 mutant animals 
show that animals carrying two copies of the mutant allele exhibit early lethality. This 
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applies to all alleles except Lipin IF_276ΔK. To exclude that CRISPR/Cas9 mutagenesis 
caused secondary unintended mutations that caused the lethal phenotype, we analyzed 
lethality of animals that carried the mutagenized chromosome over a different 
chromosome that carried a deletion of the lipin locus (Df(2R)Exel7095). The scheme for 
all conducted crosses is Mut /CyO-GFP x Df(2R)Exel7095/CyO-GFP. This cross results 
in offspring of the following genotypes: 
Mut / Df(2R)Exel7095 
Mut / CyO-GFP 
Df(2R)Exel7095 /CyO-GFP 
From these expected outcomes we can determine whether Mut / Df(2R)Exel7095 
genotype is viable by analyzing presence of GFP in the offspring. Presence of non-GFP 
animals signifies that Df(2R)Exel7095 chromosome that does not contain a functional 
copy of Lipin was able to rescue the animal carrying a mutant lipin allele. If that was the 
case, then we would know that there is a secondary mutation present on the 
mutagenized chromosome and that the mutant lipin allele is in fact functional and can 
rescue the deficiency chromosome. 
 Our data indicate that selected frame shift mutants used for this cross showed no 
rescue by the deficiency chromosome (Figure 7). This means that these animals indeed 
do not contain a functional copy of lipin and that lethality is not caused by a second-site 
mutation. Previously, we observed early larval lethality of homozygous flies with a lipin 
allele causing KTK deletion in the NLS region. However, a cross of these animals with 
Lipin deficiency animals resulted in no lethality. This outcome indicates that the 
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observed lethality was indeed caused by a second site mutation and not by the KTK 
deletion. Before these animals may be used for further experiments, the second-site 
mutation needs to be removed from the chromosome by genetic recombination. 
Figure 7. Frame shift mutants derived from CRISPR/Cas9 lines were crossed with 
Df(2R)Exel7095/CyO-GFP. Flies carrying a copy of lipin with a frameshift mutation 
were not able to survive. The animals carrying an in-frame lipin mutation were able to 
survive over the deficiency allele. 
G. Testing Mutant Animals for Predicted Lipin Protein Product Sizes 
It was mentioned earlier that lipin alleles that contain-frame shift mutations are 
expected to produce Lipin protein of reduced size. The in-frame deletion mutation also 
will cause a change in the final Lipin protein size but it will be insignificant (1 or 3 amino 
acids from 1089). Western blot protocol was used in order to visualize and analyze if the 
predicted protein sizes for the mutants can be observed. In order to achieve this goal, 
whole fat bodies from 3rd instar larvae were dissected and the total protein was 
extracted. The w1118 animals were used as a control. The protein of the samples was run 
on an SDS-PAGE gel. A polyclonal anti-NLIP domain of Lipin primary antibody was 
used (even the truncated proteins should be detected). The first gels were produced 
using 15% resolving gel and loading 10 μL of each sample. Figure 7 shows the images of 
the gels obtained from this set up.  
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Figure 8. Heterozygous lipin mutants that carry frameshift mutations express a full-
length Lipin protein but the expected truncated protein is not observed (15% resolving 
gel). (A) Loading sequence: 1-Protein ruler, 2-w
1118
, 3-LipinNLS0Δ2FS304, 4-
LipinNLS+2Δ1FS284, 5-LipinNLS+2Δ1FS284, 6-LipinNLS+2Δ5FS303, 7-LipinNLS-
6Δ13FS280, and 8-LipinNLS-3Δ7FS282. (B) Loading sequence: 1-Protein ruler, 2-
empty, 3-LipinΔNLS, 4-LipinNLS+6(+2)FS285, 5-LipinNLS-47Δ47(+1)FS269, 6-
LipinNLS0Δ1FS284, and 7-w
1118
. 
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The expected protein size for wild-type Lipin is approximately 220 kDa. The 
expected size for the truncated proteins as a result of an early stop codon in-frame shift 
mutants ranges from 29 kDa to 33 kDa. Unfortunately, all protein samples that were run 
show a diffuse band in the region where the truncated protein would be expected to be, 
including the control. These outcomes are likely due to protein degradation that has 
taken place. It is possible that the truncated protein is present but it can either be 
covered by the degradation product of the same size or the truncated protein simply 
cannot be visualized at the used total protein concentration. The truncated protein may 
not be visualized if the amount of antibody that binds to it is too low. In that case we 
would see nice bands for wild-type Lipin and the truncated Lipin that is also produced 
may be just below the detection levels.  
To test the first scenario of low detection threshold, the samples were re-run at 
twice the concentration as before. A 10% resolving gel was used this time to allow for 
better separation of the bands that can potentially be very close in size. Figure 8 shows 
the outcomes of the second run. There was an increase of degradation products that 
made proper evaluation of the results impossible.  
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Figure 9. Heterozygous lipin mutants that carry frameshift mutations in a single copy 
of lipin gene express a full length Lipin protein but the expected truncated protein is not 
observed (10% resolving gel). (A) Loading sequence: 1-Protein ruler, 2-w
1118
, 3-
LipinNLS0Δ1FS284, 3-LipinNLS+2Δ1FS284, 5-LipinNLS-47Δ47(+1)FS269, 6-
LipinNLS0Δ2FS304, and 7-LipinΔNLS. (B) Loading sequence: 1-Protein ruler, 2-w
1118
, 
3-LipinNLS-3Δ7FS282, 4-LipinNLS+2Δ5FS303, 5-LipinNLS-6Δ13FS280, and 6-
LipinNLS+6(+2)FS285. 
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H.  Function of Lipin in Malpighian Tubules 
The importance of nuclear functions of Lipin in different tissues of Drosophila is 
not understood. Malpighian tubules in the larvae of Drosophila are excretory organs 
similar to the kidneys of vertebrates. It has been shown that w1118 animals exhibit strong 
nuclear localization of Lipin in their Malpighian tubules under standard conditions 
(Ugrankar et al., 2011). It has also been shown that LipinΔNLS has a dominant negative 
effect on endogenous Lipin and prevents it from nuclear entry (Schmitt et al., 2015). The 
function of Lipin in the nucleus of Malpighian tubules is not understood and thus this 
part of the project focused on answering if exclusion of Lipin from the nucleus leads to a 
detectable phenotype. If LipinΔNLS is expressed in tubule principal cells of Malpighian 
tubules, will the development of larvae be affected? If the level of Lipin is downregulated 
via RNAi, will there be an effect on development of the larvae?  
To answer these questions, the UAS/GAL4 system was used in order to target 
Malpighian tubules only and either express LipinΔNLS or Lipin[RNAi]. Two drivers for 
Malpighian tubules were used for both experiments, C42 and Uro-GAL4. UAS-
LipinΔNLS, UAS-Lipin[RNAi], and UAS-LipinWT were the responders used in this 
experiment. UAS-LipinWT was used as a control.  
Figure 9 shows the outcomes of expressing LipinΔNLS in Malpighian tubules 
using C42 and Uro-GAL4. The crosses between w1118 and either UAS-LipinΔNLS or C42 
were used as controls. Comparing the two experimental groups, C42 > UAS-LipinΔNLS 
and Uro-GAL4 > UAS-LipinΔNLS, to the control groups, no statistical difference was 
determined (unpaired t test; p>0.05). 
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Figure 10. Overexpression of LipinΔNLS in Malpighian tubules using C42 or Uro-
GAL4 drivers. When LipinΔNLS is overexpressed using C42 or Uro-GAL4 there is no 
developmental effect on the animals (p>0.05). 
 The same strategy was used for analyzing the outcomes of RNAi experiment. This 
time C42 / w1118 was used as a control, and C42 > UAS-Lipin[RNAi] and Uro-GAL4 > 
Lipin[RNAi] were used as experimental groups. No developmental delays were observed 
(animal lethality was not evaluated due to high standard deviation within biological 
replicates).  
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Figure 11. Lipin downregulation using C42 and Uro-GAL4 Malpighian tubule drivers 
does not result in a significant developmental delay compared to controls. After 
performing a t-test comparing daily pupariation rates, no statistical differences were 
observed among groups (p>0.05). 
 Malpighian tubules were stained with Lipin antibody to affirm its nuclear 
localization in w1118. The 3rd instar larvae were dissected and Lipin protein was labeled in 
fat body and Malpighian tubules simultaneously. The outcomes of the Lipin staining did 
not match previous data because Malpighian tubules did not show high Lipin 
concentration in the nucleus (Figure 12). The difference in the outcomes may potentially 
arise from the fact that animals from crowded vials were used for the staining that were 
potentially nutritionally stressed. The nutritional stress these animals experienced 
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would come from high competition for food as a result of overcrowding. In summary, 
Lipin staining in Malpighian tubules revealed that there may be a variation in Lipin 
localization in the nucleus in response to environmental factors. 
Figure 12. Lipin protein staining shows strong cytoplasmic localization in the cells of 
fat body but not as strong in Malpighian tubules in w
1118
 (wild-type) animals. (A) and 
(D) are nuclei labeled with DAPI of fat body and Malpighian tubules respectively. (B) 
and (E) are Lipin labeled with Cy3. (C) and (F) are image overlaps for DAPI nuclear 
staining and Cy3 Lipin protein staining. The total magnification used was x100 and 
exposure of 300 ms.  
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I. Overexpression of LipinΔNLS in the Ring Gland 
Animals that exhibit developmental delay as a result of dominant negative effect of 
LipinΔNLS can be rescued if fed with 20-hydroxyecdysone (20-E), which is a steroid 
hormone that determines transitions between larval stages and into an adult (Lehmann 
lab, unpublished observations). A precursor of 20-E, ecdysone, is produced in the 
prothoracic gland portion of the ring gland. The ring gland of wild-type animals 
contains high levels of Lipin protein (Ugrankar et al., 2011). When LipinΔNLS is 
expressed in ring gland using phmN1 driver, significant developmental delay is observed 
(M. Lehmann, personal communication). The question addressed in this portion of the 
thesis is: Will expression of LipinΔNLS using cell type specific drivers for ring gland 
have a negative effect on animal development? 
This question was addressed using the GAL4/UAS system. Two different drivers 
were used to express either LipinΔNLS or LipinWT in different regions of the ring gland. 
The first driver was Mai60, which is specific for the prothoracic gland portion of the ring 
gland. The second driver was Aug21, a driver specific to the corpora allata portion of the 
ring gland. The significance of using these two drivers is that, as mentioned earlier, 
prothoracic glad produces ecdysone and corpora allata produces juvenile hormone. The 
two hormones work together to ensure proper insect development but have 
fundamentally different functions (Dubrovsky, 2005). Unlike 20-E, juvenile hormone 
does not initiate transition between the developmental stages but it does function in 
determining the type of transition that takes place. LipinΔNLS expression in both glands 
will give us an insight into the functional importance of Lipin’s nuclear localization in 
the ring gland. 
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Figure 13 shows the outcomes of expressing LipinΔNLS in ring gland using 
Mai60 and Aug21. The crosses between w1118 and either UAS-LipinΔNLS, w1118 and 
Mai60, or w1118 and UAS-LipinWT were used as controls. Comparing the four 
experimental groups, Mai60 > UAS-LipinΔNLS, Aug21 > UAS-LipinΔNLS and Mai60 > 
UAS-LipinWT, Aug21 > UAS-LipinWT to the control groups, no statistical difference 
was determined. 
Figure 13. LipinΔNLS overexpression in the ring gland using ring gland-specific 
drivers Mai60 and Aug21. Mai60 driver was used to drive expression in prothoracic 
gland and Aug21 was used to drive expression in corpora allata. When LipinΔNLS is 
overexpressed using Mai60, the animals show no significant developmental delay 
compared to control (unpaired t-test). Overexpression of LipinWT using Mai60 also 
results in no developmental delay (p>0.05).  
  
54 
 
IV. DISCUSSION 
Lipins are proteins found in an array of organisms from Arabidopsis thaliana to 
humans. These proteins participate in controls for fat storage and overall metabolism. 
Lipins can function as PAPs and as transcriptional co-regulators (Vance et al., 2004). As 
lipins’ role as transcriptional co-regulators is poorly understood, it was the goal of this 
study to establish the ground work for exploring lipin’s interactions with DNA within 
the nucleus. Lipin proteins have a nuclear localization signal (NLS), which allows their 
entry into the nucleus where the proteins directly interact with transcription control 
proteins, which leads to gene activation or repression.  
We have generated a LipinΔNLS mutant allele by utilizing CRISPR/Cas9 
mutagenesis. Our data demonstrates that LipinΔNLS is a recessive lethal allele. No 
animals that are homozygous for the mutation can be observed past the embryo stage. 
This information suggests the importance of nuclear functions of Lipin for survival.   
The LipinΔNLS allele was sequenced in order to screen for secondary mutations 
within the mutagenized lipin gene. Eleven primer pairs were used to cover the span of 
the transcript start site, 5’ UTR, all but the first two introns, and all lipin exons to the 
stop codon and including 3’ UTR. Three polymorphisms were identified in both alleles 
of the mutant. These changes were caused by two single nucleotide exchanges causing 
amino acid changes and an insertion of two nucleotides in 3’ UTR.  The LipinΔNLS 
allele contained six single nucleotide exchanges within the introns. There were also 
some other modifications not due to natural polymorphisms. The first modification was 
the NLS deletion as intended by CRISPR/Cas9 mutagenesis. The next modifications 
were single nucleotide exchanges in upstream of promoter sequence, 5’ UTR, silent 
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mutations or a single missense mutation in exons, 3’ UTR, and downstream of the ORF . 
This information suggests that outside of NLS, LipinΔNLS allele has a few mutations, 
which are not expected to affect any of the functional Lipin domains but 
complementation analysis would be needed. 
Complementation analysis was conducted using LipinΔNLS and LipinΔPAP 
animals. Just like LipinΔNLS, LipinΔPAP animals can only be heterozygous for the 
mutant allele. When crossed, we found that the two alleles can complement one another. 
It already has been shown that mammalian lipin-1 forms homo-oligomers with itself 
(Guang-Hui et al., 2010). Our suggested mechanism is that LipinΔNLS and LipinΔPAP 
can also form an oligomer, which will carry a functional PAP and a functional NLS 
domain, thus restoring the lost functions to the oligomer. The oligomerization is 
supported by observed complete rescue of the mutant phenotype.  
We were also able to retrieve some unintended mutants generated by 
CRISPR/Cas9 (See Appendix A for detailed descriptions). The majority of the mutants 
generated were frame shift mutants caused by deletions or insertions of nucleotides as a 
result of non-homologous end joining (NHEJ). Three in-frame mutation genotypes 
including LipinΔNLS were retrieved. CRISPR/Cas9 procedure was repeated three times 
to obtain the desired mutant. In the first run of CRISPR/Cas9 the protospacer did not 
function as required; there were no mutants present. In the second run, the protospacer 
directed double-strand breaks by Cas9 took place and a significant number of mutants 
was generated by NHEJ; however, homology directed repair did not seem to work as no 
LipinΔNLS mutants were recovered. The third run successfully produced a LipinΔNLS 
heterozygous mutant. 
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The mutants generated by CRISPR/Cas9 were analyzed in the following manner. 
First, the sequencing results were analyzed based on the type of mutation (frame shift 
versus in-frame). The mutants were then analyzed for homozygote lethality stage. Next, 
the mutants were analyzed for secondary site mutations by crossing each of them with 
flies carrying a deficiency uncovering the lipin locus. The results suggest that all but one 
mutant lack secondary site mutations and cannot produce viable animals when a 
mutant allele is present over the lipin deficiency allele. Finally, Western blot was 
conducted to evaluate presence of truncated proteins caused by an introduction of a 
premature stop codon due to frame shift. The fat bodies from 3rd instar larvae were 
dissected and processed to extract total protein. The results of the Western blot were 
inconclusive due to Lipin protein degradation. For future, a method should be 
developed to avoid such high rates of degradation.  
The importance of nuclear localization of Lipin is well-established in Drosophila 
(Ugrankar et al., 2011). Reduced levels of Lipin affect proper development of fat bodies, 
in turn, leading to decreased starvation resistance (Ugrankar et al., 2011). However, the 
effects of Lipin’s nuclear localization in different tissues are not well-understood. In this 
project, we looked at two types of tissues: Malpighian tubules and the ring gland. 
Drosophila larval Malpighian tubules function similar to the kidneys in humans. It was 
shown by Ugrankar et al. that w1118 animals exhibit strong nuclear localization 
preference for Lipin (2011). We also know that LipinΔNLS has a dominant negative 
effect on endogenous Lipin and prevents it from nuclear entry (Schmitt et al., 2015). We 
first expressed LipinΔNLS using Malpighian tubule-specific driver. The animals were 
observed for developmental delays. This severe phenotype was not noted as a result of 
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LipinΔNLS expression. We then expressed Lipin[RNAi] to downregulate the amount of 
Lipin present in Malpighian tubules alone. There was also no significant effect observed. 
Analyzing developmental delay as an outcome from manipulating Lipin gene expression 
in a particular tissue does not reveal effects that are of physiological importance, but do 
not impact normal development. There may be other impacts of the performed 
manipulation that would not result in a developmental delay. The primary function of 
Malpighian tubules is excretory and osmoregulatory (Nicholls 1985). The effect of low 
Lipin level or lack of Lipin’s nuclear localization may be more noticeable if Malpighian 
tubules are observed under stress conditions. Their ability to retain water in dry 
conditions, as well as rate of waste section or urine formation can be evaluated (Nicholls 
1985). More experimental work would have to be completed to assess the mechanism of 
Lipin’s nuclear function in Malpighian tubules in the future. 
The second tissue that was tested for the importance of Lipin’s nuclear 
localization was the ring gland. The effects of LipinΔNLS expression in prothoracic 
gland and corpora allata were evaluated. We were not able to observe any 
developmental delays for animals that expressed LipinΔNLS in either of the cases. Our 
laboratory previously showed an effect of LipinΔNLS expression in prothoracic gland on 
larval development using the ring gland-specific phmN1 GAL4 driver (Unpublished 
data). It is known from the literature that there is a significant variation in the strength 
of the drivers (Pfeiffer et al., 2010). In other words, not all drivers that are either 
ubiquitous or tissue-specific will result in equal rates of target gene transcription. It is 
likely that the strength of the drivers used in this project was not sufficient to cause a 
developmental delay.  
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In conclusion, this project was able to achieve the primary goal of generating and 
identifying a LipinΔNLS mutant. We were not able to generate a stock that would be 
homozygous for the LipinΔNLS allele. We can conclude that nuclear localization of 
Lipin is essential for animal survival. Possession of this mutant line opens a number of 
possibilities for future research. For example, tissue specific drivers can now be used in 
LipinΔNLS background to express LipinWT or LipinΔPAP that carry a functional NLS. 
These types of rescue experiments will help identify the tissues where nuclear 
localization of Lipin is essential for animal’s development. Although we were unable to 
observe significant effects of expressing LipinΔNLS transgene in Malpighian tubules or 
in the ring gland by our chosen methodology and evaluation criteria, the generation of a 
LipinΔNLS mutant provides a variety of future directions that can be pursued by our 
laboratory. 
V. REFERENCES 
Chatterjee D, Katewa SD, Qi Y, Jackson SA, Kapahi P, Jasper H. (2014). Control of 
metabolic adaptation to fasting by dILP6-induced insulin signaling in Drosophila 
oenocytes. Proc Natl Acad Sci U S A.;111(50):17959-64.  
Chen Z, Gropler MS, Norris J, et al. (2008). Alternations in hepatic metabolism in fld 
mice reveal a role of lipin-1 in regulating VLDL-triacylglyceride secretion. 
Arterioscler Thromb Vsc Biol 28:1738-1744. 
DiAngelo, JR and Birnbaum, MJ.(2009). Regulation of fat cell mass by insulin in 
Drosophila melanogaster. Mol. Cell. Biol. 29, 6341–6352. 
Donkor J, Sariahmetoglu M, Dewald J, et al. (2007). Three mammalian lipins act as 
phosphotidate phosphatases with distinct tissue expression patterns. J Biol Chem 
282:3450-3457. 
Dubrovsky EB. Hormonal cross talk in insect development. (2005). Trends in 
Endocrinology and Metabolism 16(1):6-11·  
Echalier G. (1997). Drosophila Cells in Culture, Academic Press, San Diego.10.  
59 
 
Echalier G. and Ohanessian, A. (1969). Isolation, in tissue culture, of Drosophila 
melanogaster cell lines. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D. 268, 1771–
1773.  
El-Shanti HI, Ferguson PJ. (2007). Chronic recurrent multifocal osteomyelitis: a concise 
review and genetic update. Clin Orthop Relat Res 462:11-19. 
Ferguson PJ, Chen S, Teyeh MK, et al. (2005). Homozygous mutations in LPIN2 are 
responsible for the syndrome of chronic recurrent multifocal osteomyelitis and 
congenital dyserythropoetic anaemia (Majeed syndrome). J Med Genet 42:551-
557. 
Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence Jr. JC, and 
Kelly DP. (2006). Insulin controls subcellular localization and multisite 
phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem 282, 
277-286. 
Finck* BN, Gropler MC, Chen Z, et al. (2006). Lipin 1 is an inducible amplifier of the 
hepatic PGC-1alphaPPARalpha regulatory pathway. Cell Metab 4:199-210. 
Garg A. Aquired and inherited lipodystrophies. (2004). N Engl J Med 350, 1220-1234. 
Green C. J., Pramfalk C., Morten K. J. and Hodson L. (2015). From whole body to 
cellular models of hepatic triglyceride metabolism: man has got to know his 
limitations. Am. J. Physiol. Endocrinol. Metab. 308, E1-E20.  
Guang-Hui L, Qu J, Carmack AE, Kim HB, Chen C, Ren H, Morris AJ, Finck BN, and 
Harris TE. (2010). Lipin proteins form homo- and hetero-oligomers. Biochem J. 
432(1): 65–76. 
Gutierrez E, Wiggins D, Fielding B, Gould AP. (2007). Specialized hepatocyte-like cells 
regulate Drosophila lipid metabolism.  Nature 445(7125): 275-280. 
Hans GS, Wu WI, Carman GM. (2006). The Saccharomyces cereviciae lipin homolog is 
a Mg2+ dependent phosphotidate phosphatase enzyme. J Biol Chem 281:9210-
9218. 
Harris, T E and Finck, B N. (2011). Dual function lipin proteins and glycerolipid 
metabolism. Trends Endocrinol. Metab. 22, 226–233. 
Harris TE, Huffman TA, Chi A, et al. (2007). Insulin controls subcellular localization 
and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J 
Biol Chem 282:277-286. 
Huffman TA, Mothe-Satney I, Lawrence JC Jr. (2002). Insulin0stimulated 
phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc 
Natl Acad Sci USA 99, 1047-1052. 
Kim SK, and Rulifson EJ. (2004). Conserved mechanisms of glucose sensing and 
regulation by Drosophila corpora cardiaca cells. Nature 431:316-320. 
60 
 
Kim Y, Gentry MS, Harris TE, et al. (2007). A conserved phosphatase cascade that 
regulated nuclear membrane biogenesis. Proc Natl Acad USA 104:6596-6601. 
Kuhnlein RP. (2011). The contribution of the Drosophila model to lipid dropolet 
research. Prog Lipid Res 50:348-356. 
Langer CA, Birkenmeier EH, Ben-Zeev O, et al. (1989). The fatty liver dystrophy (fld) 
mutation. A new mutant mouse with a developmental abnormality in triglyceride 
metabolism and associated tissue-specific defects in lipoprotein lipase and heptic 
lipase activities. J Biol Chem 264:7994-8003. 
Majeed HA, Al-Tarawna M, El-Shanti H, et al. (2001). The syndrome of chronic 
recurrent multifocal osteomyelitis and congenital dyserythropoetic anaemia. 
Report of a new family and a review. Eur J Pediatr 160:705-710. 
Milhavet F, Cuisset L, Hoffman HM, et al. (2008). The inverse autoinflammatory 
mutation online registry: update with new genes and functions. Hum Mutat 
19:803-808. 
Murphy DJ. (2012). The dynamic roles of intracellular lipid droplets: from Arcahea to 
mammals. Protoplasma 249:541-585. 
Nadra K, de Preux CSA, Medar JJ, et al. (2008). Phosphatidic acid mediates 
demyelination in Lpin1 mutant mice. Genes Dev 22:1647-1661.  
Nicholls SP. (1985). Fluid secretion by the Malpighian tubules of dragonfly Libellula 
quadrimaculata. Printed in Great Britain © The Company of Biologists Limited. 
Péterfy M, Phan J, Xu P, and Reue K. (2001). Lipodystrophy in the fld mouse results 
from mutation of a new gene encoding a nuclear protein, lipin. Nat Gener 27, 121-
124. 
Péterfy M, Harris TE, Fujita N and Reue K. (2010). Insulin-stimulated interaction with 
14-3-3 promotes cytoplasmic localization of lipin-1 in adipocytes. J. Biol. Chem. 
285, 3857–3864. 
Petersen, UM, Kadalayil L, Rehorn KP, Hoshizaki DK, Reuter R and Engstrom Y. (1999). 
Serpent regulates Drosophila immunity genes in the larval fat body through an 
essential GATA motif. EMBO J. 18, 4013–4022. 
Pfeiffer BD, Ngo T-TB, Hibbard KL, et al. (2010). Refinement of Tools for Targeted 
Gene Expression in Drosophila. Genetics 186(2):735-755.  
Phan J and Reue K. (2005). Lipin, lipodystrophy and obesity gene. Cell Metab 1, 73-83. 
Phan J, Péterfy M, Rue K. (2004). Lipin expression preceding peroxisome-proliferator 
activated receptor gamma is critical for adipogenesis in vivo and in vitro. J Biol 
Chem 279:29558-295664. 
61 
 
Port F, Chen HM, Lee T, Bullock SL. (2014). Optimized CRISPR/Cas tools for efficient 
germline and somatic genome engineering in Drosophila. Proc Natl Acad Sci U S 
A. 111(29):E2967-76. 
Richardson CD, Ray GJ, DeWitt MA, Curie GL, Corn JE. (2016). Enhancing homology-
directed genome editing by catalytically active and inactive CRISPR-Cas9 using 
asymmetric donor DNA. Nature Biotechnology 34, 339–344. 
Rulifson EJ, Kim SK and Nusse R. (2002). Ablation of insulin-producing neurons in 
flies: growth and diabetic phenotypes. Science 296, 1118–1120. 
Saltiel AR and Kahn CR. (2001). Insulin signaling and the regulation of glucose and  
Santos-Rosa H, Leung J, Grimsey N, Peak-Chew S, and Siniossoglou S. (2005). The 
yeast lipin  Smp2 couples phospholipid biosynthesis to nuclear membrane 
growth. EMBO J 24, 1931-1941. 
Schmitt S, Ugrankar R, Greene SE, Prajapati M, and Lehmann M. (2015). Drosophila 
Lipin interacts with insulin and TOR signaling pathways in the control of growth 
and lipid metabolism. J Cell Sci. 128(23):4395-406.  
Sirvent P, Mercier J, Lacampagne A. (2008). New insights into mechanisms of statin-
associated myotoxicity. Curr Opin Pharmacol 8:333-338. 
Smyth S and Heron A. (2006). Diabetes and obesity: the twin epidemics. Nat Med 12, 
75-80. 
Ugrankar R, Liu Y, Provaznik J, Schmitt S, and Lehmann M. (2011). Lipin is a central 
regulator of adipose tissue development and function in Drosophila 
melanogaster. J Cell Biol 1, 1646-1656.  
Vance JE and Vance DE. (2004). Phospholipid biosynthesis in mammalian cell. 
Biochem Cell Biol 82, 113-128. 
Wullschleger S, Loewith R and Hall MN. (2006). TOR Signaling in Growth and 
Metabolism. Cell 124, 471–484. 
Zechner R, Strauss JG, Haemmerle G, Lass A and Zimmermann R. (2005). Lipolysis: 
pathway under construction. Curr. Opin. Lipidol. 16, 333-340. 
Zeharia A, Shaag A, Houtkooper RH, et al. (2008).Mutations in LPIN1 cause recurrent 
acute myoglobinuria in childhood. Am J Hum Genet 83:1-6. 
62 
 
VI. APPENDIX: NUCLEOTIDE AND AMINO ACID ALIGNMENTS OF 
CRISRPR/CAS GENERATED MUTANTS 
A. LipinNLS+6(+2)FS285 
Figure 14. FS277 CRISPR mutagenized animal. This frame shift animal genotype has a 
two nucleotide insertion AG, which results in premature stop codon at position 285. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKTKKSGARSRK  Stop 
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B. LipinNLS_IF276ΔK 
Figure 15. IF276 CRISPR mutagenized animal. This in-frame mutation animal 
genotype lack AAG or K as a part of the start of NLS sequence. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKTKΔRRKKSQMKKNAQRKNSSSSSLGS 
AGGGDLPSAETPSLGVSNIDEGDAPISSATNNNNTSSSNDEQLSAPLVTA 
RTGDDSPLSEIPHTPTSNPRLDLDIHFFSDTEITTPVGGGGAGSGRAAGG 
RPSTPIQSDSELETTMRDNRHVVTEESTASWKWGELPTPEQAKNEAMSAA 
QVQQSEHQSMLSNMFSFMKRANRLRKEKGVGEVGDIYLSDLDAGSMDPEM 
AALYFPSPLSKAASPPEEDGESGNGTSLPHSPSSLEEGQKSIDSDFDETK 
QQRDNNRYLDFVAMSMCGMSEQGAPPSDEEFDRHLVNYPDVCKSPSIFSS 
PNLVVRLNGKYYTWMAACPIVMTMITFQKPLTHDAIEQLMSQTVDGKCLP 
GDEKQEAVAQADNGGQTKRYWWSWRRSQDAAPNHLNNTHGMPLGKDEKDG 
DQAAVATQTSRPTSPDITDPTLSKSDSLVNAENTSALVDNLEELTMASNK 
SDEPKERYKKSLRLSSAAIKKLNLKEGMNEIEFSVTTAYQGTTRCKCYLF 
RWKHNDKVVISDIDGTITKSDVLGHILPMVGKDWAQLGVAQLFSKIEQNG 
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YKLLYLSARAIGQSRVTREYLRSIRQGNVMLPDGPLLLNPTSLISAFHRE 
VIEKKPEQFKIACLSDIRDLFPDKEPFYAGYGNRINDVWAYRAVGIPIMR 
IFTINTKGELKHELTQTFQSSGYINQSLEVDEYFPLLTNQDEFDYRTDIF 
DDEESEEELQFSDDYDVDVEHGSSEESSGDEDDDEALYNDDFANDDNGIQ 
AVVASGDERTADVGLIMRVRRVSTKNEVIMASPPKWINS 
 
C. LipinNLS_IF273ΔKTK 
Figure 16. IF273 CRISPR mutagenized animal. This in-frame mutation animal 
genotype lack AAAACCAAG or KTK as a part of the start of NLS sequence. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSΔKRRKKSQMKKNAQRKNSSSSSLGS 
AGGGDLPSAETPSLGVSNIDEGDAPISSATNNNNTSSSNDEQLSAPLVTA 
RTGDDSPLSEIPHTPTSNPRLDLDIHFFSDTEITTPVGGGGAGSGRAAGG 
RPSTPIQSDSELETTMRDNRHVVTEESTASWKWGELPTPEQAKNEAMSAA 
QVQQSEHQSMLSNMFSFMKRANRLRKEKGVGEVGDIYLSDLDAGSMDPEM 
AALYFPSPLSKAASPPEEDGESGNGTSLPHSPSSLEEGQKSIDSDFDETK 
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QQRDNNRYLDFVAMSMCGMSEQGAPPSDEEFDRHLVNYPDVCKSPSIFSS 
PNLVVRLNGKYYTWMAACPIVMTMITFQKPLTHDAIEQLMSQTVDGKCLP 
GDEKQEAVAQADNGGQTKRYWWSWRRSQDAAPNHLNNTHGMPLGKDEKDG 
DQAAVATQTSRPTSPDITDPTLSKSDSLVNAENTSALVDNLEELTMASNK 
SDEPKERYKKSLRLSSAAIKKLNLKEGMNEIEFSVTTAYQGTTRCKCYLF 
RWKHNDKVVISDIDGTITKSDVLGHILPMVGKDWAQLGVAQLFSKIEQNG 
YKLLYLSARAIGQSRVTREYLRSIRQGNVMLPDGPLLLNPTSLISAFHRE 
VIEKKPEQFKIACLSDIRDLFPDKEPFYAGYGNRINDVWAYRAVGIPIMR 
IFTINTKGELKHELTQTFQSSGYINQSLEVDEYFPLLTNQDEFDYRTDIF 
DDEESEEELQFSDDYDVDVEHGSSEESSGDEDDDEALYNDDFANDDNGIQ 
AVVASGDERTADVGLIMRVRRVSTKNEVIMASPPKWINS 
 
D. LipinNLS0Δ1FS284 
Figure 17. FS275 CRISPR mutagenized animal. This frame shift animal genotype has a 
one nucleotide deletion A, which results in premature stop codon at position 284. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
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QIKPDVNLTTVTTSEATKEVSKSKTRSGARSRK Stop 
 
E. LipinNLS+2Δ1FS284 
Figure 18. FS275 CRISPR mutagenized animal. This frame shift animal genotype has a 
one nucleotide deletion at the beginning of the NLS sequence, G, which results in 
premature stop codon at position 284. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKTRSGARSRK Stop 
 
 
 
 
67 
 
F. LipinNLS0Δ2FS304 
Figure 19. FS275 CRISPR mutagenized animal. This frame shift animal genotype has a 
two nucleotide deletion at the beginning of the NLS sequence, AA, which results in 
premature stop codon at position 304. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKTEAAQEVANEEECPAQELFKQLIGQRRRR 
Stop 
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G. LipinNLS+2Δ5FS303 
 
Figure 20. FS276 CRISPR mutagenized animal. This frame shift animal genotype has a 
five nucleotide deletion at the beginning of the NLS sequence, GAAGC, which results in 
premature stop codon at position 303. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKTKAQEVANEEECPAQELFKQLIGQRRRR 
Stop 
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H. LipinNLS0Δ5FS303 
Figure 21. FS275 CRISPR mutagenized animal. This is a frame shift mutation and the 
animal has genotype that lacks five nucleotides, AAGAA, at the beginning of NLS 
sequence results in premature stop codon at position 303. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKTAAQEVANEEECPAQELFKQLIGQRRRR 
Stop 
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I. LipinNLS-3Δ7FS282 
Figure 22. FS274 CRISPR mutagenized animal. This frame shift animal genotype has a 
seven nucleotide deletion ACCAAGA, which results in premature stop codon at position 
282. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSKSGARSRK Stop 
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J. LipinNLS-6Δ13FS280 
Figure 23. FS273 CRISPR mutagenized animal. This frame shift animal genotype has a 
13 nucleotide deletion AAAAACAAGAAGC, which results in premature stop codon at 
position 280. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTTVTTSEATKEVSKSGARSRK Stop 
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K. LipinNLS-47Δ47(+1)FS269 
Figure 24. FS259 CRISPR mutagenized animal. This frame shift animal genotype has a 
47 nucleotide deletion 
ACGGTCACAACCAGCGAAGCCACCAAGGAGGTGTCCAAGAGCAAAAC, and either a 
point mutation which introduces G instead of the first A in the deleted sequence, or, 
more likely, an insertion of a G at the cut site, which results in premature stop codon at 
position 269. 
Modified protein derived from the mutagenized Lipin allele: 
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGK 
LGVLRSREKVVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANL 
ATSPIPNSFLASRDKANDTMEDISGVVTDKNASEELLLPLPLPRRNSIDF 
SKEEPKEAVVEGSKFENQVSDYTQRRHTDNTLERRNLSEKLKEFTTQKIR 
QEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIPAVIEDTEKEKD 
QIKPDVNLTARSGARSRK Stop 
 
